These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22915799)

  • 1. HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.
    Phalora PK; Sherer NM; Wolinsky SM; Swanson CM; Malim MH
    J Virol; 2012 Nov; 86(21):11712-24. PubMed ID: 22915799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
    Li J; Chen Y; Li M; Carpenter MA; McDougle RM; Luengas EM; Macdonald PJ; Harris RS; Mueller JD
    J Mol Biol; 2014 Mar; 426(6):1296-307. PubMed ID: 24361275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
    Wichroski MJ; Robb GB; Rana TM
    PLoS Pathog; 2006 May; 2(5):e41. PubMed ID: 16699599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
    Marin M; Golem S; Rose KM; Kozak SL; Kabat D
    J Virol; 2008 Jan; 82(2):987-98. PubMed ID: 17977970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction with 7SL RNA but not with HIV-1 genomic RNA or P bodies is required for APOBEC3F virion packaging.
    Wang T; Tian C; Zhang W; Sarkis PT; Yu XF
    J Mol Biol; 2008 Jan; 375(4):1098-112. PubMed ID: 18067920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
    Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
    J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
    Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
    J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.
    Kobayashi T; Koizumi Y; Takeuchi JS; Misawa N; Kimura Y; Morita S; Aihara K; Koyanagi Y; Iwami S; Sato K
    J Virol; 2014 May; 88(10):5881-7. PubMed ID: 24623435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
    Zhou T; Han Y; Dang Y; Wang X; Zheng YH
    Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.
    Albin JS; Harris RS
    Expert Rev Mol Med; 2010 Jan; 12():e4. PubMed ID: 20096141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
    Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
    J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
    Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
    J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
    Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
    J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
    Hakata Y; Landau NR
    J Biol Chem; 2006 Dec; 281(48):36624-31. PubMed ID: 17020885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
    Zhao W; Akkawi C; Mougel M; Ross SR
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vif, APOBEC, and intrinsic immunity.
    Goila-Gaur R; Strebel K
    Retrovirology; 2008 Jun; 5():51. PubMed ID: 18577210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
    Han Y; Wang X; Dang Y; Zheng YH
    PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.